[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BowTiedBiotech Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1462941795520638981.png) BowTiedBiotech 🧪🔬🧬 [@BowTiedBiotech](/creator/twitter/BowTiedBiotech) on x 19.7K followers
Created: 2025-07-05 11:31:12 UTC

10/ 🏁 TLDR

Swiss pharma was sitting under a tariff shadow.

This deal? It just turned on the lights.

Roche, Novartis, Lonza, and Galderma all benefit.

But the real upside is M&A, and the return of deal appetite across borders.

The discount is closing. Watch it move.


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1941459843908600069/c:line.svg)

**Related Topics**
[discount](/topic/discount)
[$galdsw](/topic/$galdsw)
[$lonnsw](/topic/$lonnsw)
[tariffs](/topic/tariffs)
[swiss](/topic/swiss)
[novartis](/topic/novartis)
[$novnsw](/topic/$novnsw)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/BowTiedBiotech/status/1941459843908600069)